Rezultati
eNauka >
Rezultati >
Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial.
Naziv: | Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial. | Autori: | Rigas, James R; Schuster, Michael W; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey T | Godina: | 2010 | Publikacija: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X![]() ![]() |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 28 br. 15 | WoS-ID: | 000208852005002 | URI: | https://enauka.gov.rs/handle/123456789/801173 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.